2026. A NEW GENE THERAPY PARADIGM IN VIVO CRISPR ENGINEERING OF HEMATOPOIETIC NICHES FOR CANCER IMMUNOTHERAPY. Frontier in Medical and Health Research. 4, 6 (Jun. 2026), 1756–1802.